Many of the interactions which have been documented with alprazolam are with prescription drugs that modulate CYP3A4 exercise. Compounds which have been inhibitors or inducers of CYP3A could be expected to raise or lessen plasma alprazolam concentrations, respectively. Drug products that were researched in vivo, along with their impact on raising a